BioAscent Discovery Ltd is PE backed leading provider of integrated drug discovery services, including compound management, biology and medicinal/synthetic chemistry services, and compound library provision via Compound Cloud.The company was recently nominated in “High Growth” and “Rising star” categories for Scottish Life Sciences Awards.

Various senior finance roles. For example Engineering, Biotech, SaaS

Trust Housing Association is a national provider of housing support and care services. Appointed on an interim basis as Finance Director pending the appointment of a full time F.D.

Ryboquin Ltd and Nanogenics Ltd are Biotech companies engaged in the development of certain gene and cancer therapies. The companies also hold the Intellectual Property of "Liptide" an artificial virus effective in many gene therapy techniques. Since joining I have been active in the completion of the company business plan, fund raising (£5m) and in acquiring the rights to the Liptide platform.

Cyklop International is a global manufacturer of universal packaging solutions. The company operates in over 20 countries worldwide, predominately in Europe, South America and Asia.Working alongside the group CEO , responsible on a consultancy basis for overseeing and directing organisational financial goals and objectives and rolling forecasts. Regular meetings with Board and other company executives to develop financial strategy.Strategic projects include:Group restructuring to take advantage of legal and tax efficiencies.investment appraisal of overseas company acquisition.financial due diligence - both acquisition and disposal.business turnaround.

Appointed to oversee all aspects of the Finance and I.T. functions and to strengthen financial management of the business, accounting processes and financial reporting. Contributed to the strategic direction of the business.Completed £30m finance proposal regarding acquisition of new production facility to supplement existing operations in Scotland in order to position the business strategically for growth.

An international contract research organisation managing the conduct and staffing of global clinical trials for the pharmaceutical and biotechnology industries. Operating in 26 countries with1,600 staff and revenues of $200million.• Holding full accountability and ownership of the entire financial performance of the Group.• Overseeing and effectively managing working capital, debt levels, banking covenants, taxes, budgets, forecasts and FX hedging.• Providing leadership to a team (55 staff worldwide) responsible for developing financial plans and producing meaningful and timely financial management information• Aligning financial plans with the Group’s strategic business plan, growth objectives, market opportunities and direction• Ensuring strict compliance with international GAAPKey achievements:• Achieving rapid internal promotion, having joined the company in 2009 as a Financial Systems Project Manager, progressing to Group Financial Controller in 2010 and attaining the position of CFO in 2012• Partnering the Chairman and CEO to successfully secure refinancing for the Group through financial due diligence and presentations to potential lenders• Partnering with the Chairman, CEO and other Board Members to plan and implement the Group sale process, with responsibility for financial due diligence and delivering financial presentation to prospective buyers• Significantly improving financial capabilities by implementing a worldwide finance system which delivered better discipline in reporting and financial control and improved visibility of accounting processes

Part of Kendle Inc., a USA SEC-listed clinical research service company and the fourth largest worldwide• Spearheading financial leadership and reporting across the UK operation and 7 other subsidiaries across Europe, with revenues of over $150million per annum• Providing effective leadership and direction to the European-wide finance team, to ensure that all financial obligations of the 5-year business plan and annual business plan were achievedKey achievements:• Improving financial reporting by restructuring the European Finance Team to meet the demands of a growing business, including reducing the complexity of key management reports to increase confidence• Winning US Corporate Office approval for a business case to implement a new European financial and management reporting system, which was delivered on time and on budget• Improving month-end procedures to enable reports to be prepared one day after period end, with full financial reports available within 4 days of month end• Achieving a £600,000 profit benefit and £300,000 cash flow benefit by enhancing the system used to capture and analyse the costs associated with work in progress• Reducing costs and improving standards of financial reporting across Europe by consolidating Advisors, minimising reporting times and implementing transfer pricing arrangements• Developing a rolling forecast model highlighting key business drivers and rolling it out across Europe, resulting in improved forecasting, increased added value and elimination of annual budgeting processes• Managing development of financial system documentation related to internal controls, to achieve compliance with the Sarbannes-Oxley act• Managing due diligence during the sale of the European business, including overseeing 6 audits, 3 tax investigations and a new system implementation within a 12 month period

The world’s leading poultry breeding/genetics group, owned by venture capitalists, operating in 100 countries with revenues in excess of $700million• Holding full responsibility for all financial reporting of the UK parent company and 3 European subsidiaries• Preparing investment plans, drafting joint venture agreements and managing the expectations of stakeholders in relation to these investments• Conducting feasibility studies into the potential for establishing operations in the Middle East, Eastern Europe and Asia• Monitoring the financial performance of a network of distributorsKey achievements:• Acting as Board Director for 3 European joint ventures, and also contributing significantly to Middle Eastern, Central European and Turkish regional management teams• Taking ownership of a Turkish joint venture investment proposal, including rewriting the business plan, winning Board approval, successfully negotiating finance from foreign banks and agreeing investment terms with a Saudi-based joint venture partner• Gaining shareholder approval for a development plan to expand the regional production base in Hungary• Improving the efficiency of annual budgeting procedures by reviewing existing processes and implementing changes• Receiving clean audit reports every year• Consistently achieving all targets

A family-owned group of 5 companies specialising in the manufacture of industrial cleaning chemicals• Devising a business plan that secured substantial additional funding and allowed the company to expand into new UK and international markets• Implementing financial plans and a new financial system for a new subsidiary in the United Arab Emirates